PEOPLE - Qiagen (Netherlands) makes appointment:
This article was originally published in Clinica
Dutch company Qiagen has appointed Dr Michael Burgett vice-president of its North American operations. Dr Burgett was most recently with Applied Imaging's genetic diagnostics division. Qiagen develops technologies and products focused on nucleic acid separation and purification.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.